The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The inflammation based index (IBI) predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
Delali Akosua Adjogatse
No relevant relationships to disclose
George Karamanakos
No relevant relationships to disclose
David James Pinato
No relevant relationships to disclose
Rohini Sharma
No relevant relationships to disclose